PAVmed Inc. Warrant (PAVMW)

$ 2.55
0.32 (+14.35%)
-
Symbol PAVMW
Price $ 2.55
Beta 0.539
Volume Avg. 0.02M
Market Cap 0.07B
Shares () -
52 Week Range 0.07-6.94
1y Target Est -
DCF Unlevered -
DCF Levered -
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update

PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update

Conference call to be held today at 4:30 p.m. Eastern timeNEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, toda... ...

Yahoo
PAVmed Secures $7 Million Convertible Note Financing

PAVmed Secures $7 Million Convertible Note Financing

NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced it has received approximately $7 million in gr... ...

Yahoo
LD Micro Announces Preliminary List of Presenters for the LD-500

LD Micro Announces Preliminary List of Presenters for the LD-500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. ...

Yahoo
PAVmed to Hold Business Update Conference Call on August 18, 2020

PAVmed to Hold Business Update Conference Call on August 18, 2020

NEW YORK, July 28, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company will host a business update c... ...

Yahoo
PAVmed to Present at Maxim Group’s COVID-19 Webinar on July 16, 2020

PAVmed to Present at Maxim Group’s COVID-19 Webinar on July 16, 2020

NEW YORK, July 13, 2020 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today. ...

Yahoo
Should You Buy PAVmed Inc. (PAVM)?

Should You Buy PAVmed Inc. (PAVM)?

In this article we will take a look at whether hedge funds think PAVmed Inc. (NASDAQ:PAVM) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dol... ...

Yahoo
PAVmed Inc (NASDAQ:PAVM) Sees Large Increase in Short Interest

PAVmed Inc (NASDAQ:PAVM) Sees Large Increase in Short Interest

PAVmed Inc (NASDAQ:PAVM) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 36.4% from the March 31st total of 1,290,000 shares. Currentl... ...

THELINCOLNIANONLINE
Company News for Apr 22, 2020

Company News for Apr 22, 2020

Companies In The News Are: SYF, VXRT, PAVM, WAFD ...

Yahoo
Edited Transcript of PAVM earnings conference call or presentation 9-Apr-20 8:30pm GMT

Edited Transcript of PAVM earnings conference call or presentation 9-Apr-20 8:30pm GMT

Q4 2019 PAVmed Inc Earnings Call ...

YAHOO
The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations

The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operat...

Biotech stocks went along with the broader market flow in the week ended April 3, with the COVID-19 pandemic dictating sentiment. The week witnessed a host of clinical readouts and pre-announcements in light of the COVID-19 impact.The stock that made... ...

YAHOO

About


Dr. Lishan Aklog M.D.
Nasdaq Capital Market

PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.